Cerebral infarction for more than half a year to take the brain cardiac capsule effect?

Cerebral infarction for more than half a year to eat the brain heart Tong has no effect, need to be diagnosed according to the patient’s condition diagnosis, generally for qi deficiency and blood stasis type of patients, eat the brain heart Tong capsule may have a certain effect. Brain Heart Capsules, composed of Astragalus, Radix Paeoniae Alba, Salviae Miltiorrhizae, Radix Angelicae Sinensis, Rhizoma Ligustici Chuanxiong and other traditional Chinese medicines, has the effect of benefiting qi and activating blood (replenishing qi and blood to make the body full of qi and blood and blood flow), resolving blood stasis and opening up the channels. It is used for stroke in the meridian caused by qi deficiency and blood stagnation, stagnation of veins and channels, hemiplegia (one side of the limb can not move freely), numbness of the limbs, crooked eyes and mouth. So patients with qi deficiency and blood stasis type cerebral infarction taking the drug has a therapeutic effect, but cerebral infarction also includes wind and yang upward disturbance (liver fire bias, upward invasion of the head and face and other parts of the body), yin deficiency and wind type cerebral infarction, its effect is limited. It should be noted that it is contraindicated for pregnant women. It is recommended to be taken after meals for patients with stomach disorders, with caution for women with bleeding tendency, menstruating women or patients using anticoagulant or antiplatelet therapy, and with caution for those with weak spleen and stomach and allergies. The drug may cause nausea, vomiting, abdominal discomfort, dry mouth, dizziness, headache, rash, palpitations, dyspnea, flushing, allergies and other adverse reactions. After cerebral infarction discomfort is recommended to consult a doctor in time, under the guidance of a Chinese medicine practitioner to identify the evidence to take medication, do not take medication on their own, in order to avoid delays in the condition or the occurrence of adverse reactions.